American researchers have identified a genetic link between
three different types of tissue cancer. They have found 20
percent of all skin, bone and brain cancers share a defective
version of a gene known as STAG2. It is now hoped the new
findings will be used to develop new treatments for all three
strains of the disease. READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Healthcare Global, click here -
Insecticide bed nets linked to malaria increase - New technology
enables keyhole surgery to ‘feel’ - Synthetically engineered
bacteria destroys superbugs The researchers, from the Georgetown
University School of Medicine, conducted the study initially to
find a mutated gene in common forms of brain cancer. They are
now going to conduct further studies to see if the gene is
present in other forms of cancer. “In the cancers we studied,
mutations in STAG2 appear to be a first step in the
transformation of a normal cell into a cancer cell," said Todd
Waldman from the university. “We are now loo